MAVI1, an endoplasmic reticulum–localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion
Science Advances · 2023
DOI: 10.1126/sciadv.adg7053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Tao-Tao Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Xiang An Biomedicine Laboratory, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiang'an South Road, Xi…. Hauptthemen laut MEDLINE: Immunity, Innate, Interferon Type I. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pattern recognition receptor–mediated innate immunity is critical for host defense against viruses. A growing number of coding and noncoding genes are found to encode microproteins. However, the landscape and functions of microproteins in responsive to virus infection remain uncharacterized. Here, we systematically identified microproteins that are responsive to vesicular stomatitis virus infection. A conserved and endoplasmic reticulum–localized membrane microprotein, MAVI1 (microprotein in antiviral immunity 1), was found to interact with mitochondrion-localized MAVS protein and inhibit MAVS aggregation and type I interferon signaling activation. The importance of MAVI1 was highlighted that viral infection was attenuated and survival rate was increased in Mavi1- knockout mice. A peptide inhibitor targeting the interaction between MAVI1 and MAVS activated the type I interferon signaling to defend viral infection. Our findings uncovered that microproteins play critical roles in regulating antiviral innate immune responses, and targeting microproteins might represent a therapeutic avenue for treating viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Xiang An Biomedicine Laboratory, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
- State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
- Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
- Bioland Laboratory (Guangzhou Regenerative Medicine and Health - Guangdong Laboratory), KaiYuan Road, Guangzhou, Guangdong 510530, China.
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, C…
ORCID-Profile: Tao-Tao Shi, Ying Huang, Ying Li, Yao-Hui He, Jian-Cheng Ding, Yang Shi, Quan Yuan, Wen-Juan Li, Wen Liu
Zitieren
APA
Shi, T. T., Huang, Y., Li, Y., Dai, X. L., He, Y. H., Ding, J. C., Ran, T., Shi, Y., Yuan, Q., Li, W. J., & Liu, W. (2023). MAVI1, an endoplasmic reticulum–localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion. Science Advances. https://doi.org/10.1126/sciadv.adg7053
Vancouver
Shi TT, Huang Y, Li Y, Dai XL, He YH, Ding JC, et al. MAVI1, an endoplasmic reticulum–localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion. Science Advances. 2023. doi:10.1126/sciadv.adg7053
BibTeX
@article{Shi2023,
author = {Shi, Tao-Tao and Huang, Ying and Li, Ying and Dai, Xiang-Long and He, Yao-Hui and Ding, Jian-Cheng and Ran, Ting and Shi, Yang and Yuan, Quan and Li, Wen-Juan and Liu, Wen},
title = {MAVI1, an endoplasmic reticulum–localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adg7053}
}
EUVIMED